EVALUATION OF FUNCTIONAL OUTCOME OF OPEN REDUCTION & INTERNAL FIXATION AND CONSERVATIVE MANAGEMENT OF TALUS FRACTURES IN TRAUMA PATIENTS - A RANDOMIZED CONTROL TRIAL
Keywords:
AOFAS, Ankle Fracture, Conservative Management, ORIF, Randomized Controlled Trial, Talus, TraumaAbstract
Background: The talus plays a critical role in ankle joint stability and mobility. Fractures of the talus, although uncommon, are associated with significant morbidity due to its unique vascular anatomy and articular coverage. Objectives: To compare the functional outcomes of ORIF versus conservative management in patients with talus fractures using the AOFAS (American Orthopaedic Foot & Ankle Society) score. Study Design & Setting: This study was conducted at the Department of Orthopedics, Rawalpindi Teaching Hospital, from 16th August 2024 to 15th February 2025. Methodology: A total of 60 with Hawkins Type B, C, or D talus fractures were randomized into two groups: 30 patients received conservative treatment and 30 underwent ORIF. Data were collected using a structured proforma. Functional outcomes were assessed using the AOFAS score at six weeks post-treatment. Data were analyzed using SPSS v23. Chi-square tests were applied to assess associations, with a p-value ≤ 0.05 considered statistically significant. Results: The mean AOFAS score was significantly higher in the ORIF group (60.58 ± 9.42) compared to the conservative group (46.33 ± 10.40), p < 0.001. Impaired outcomes (AOFAS < 50) were more frequent in the conservative group (63.3%) versus the ORIF group (13.3%). Stratified analysis showed significant associations between impaired outcomes and age, gender, and trauma type. Conclusion: ORIF resulted in significantly better short-term functional outcomes compared to conservative treatment for talus fractures. Surgical intervention should be preferred when feasible to optimize patient recovery.
Downloads
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.